BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 30189445)

  • 1. A Summary on Polycystic Ovary Syndrome: Diagnostic Criteria, Prevalence, Clinical Manifestations, and Management According to the Latest International Guidelines.
    Neven ACH; Laven J; Teede HJ; Boyle JA
    Semin Reprod Med; 2018 Jan; 36(1):5-12. PubMed ID: 30189445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Clin Endocrinol (Oxf); 2018 Sep; 89(3):251-268. PubMed ID: 30024653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
    Eur J Endocrinol; 2023 Aug; 189(2):G43-G64. PubMed ID: 37580861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Misso ML; Boyle JA; Garad RM; McAllister V; Downes L; Gibson M; Hart RJ; Rombauts L; Moran L; Dokras A; Laven J; Piltonen T; Rodgers RJ; Thondan M; Costello MF; Norman RJ;
    Med J Aust; 2018 Oct; 209(S7):S3-S8. PubMed ID: 30453865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome - an update.
    Boyle J; Teede HJ
    Aust Fam Physician; 2012 Oct; 41(10):752-6. PubMed ID: 23210095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about.
    Shorakae S; Boyle J; Teede H
    Intern Med J; 2014 Aug; 44(8):720-6. PubMed ID: 24909750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International evidence-based guideline on assessment and management of PCOS-A Nordic perspective.
    Forslund M; Melin J; Stener-Victorin E; Hirschberg AL; Teede H; Vanky E; Piltonen T
    Acta Obstet Gynecol Scand; 2024 Jan; 103(1):7-12. PubMed ID: 37983875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle and Behavioral Management of Polycystic Ovary Syndrome.
    Brennan L; Teede H; Skouteris H; Linardon J; Hill B; Moran L
    J Womens Health (Larchmt); 2017 Aug; 26(8):836-848. PubMed ID: 28570835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
    Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
    Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the barriers and enablers to implementing lifestyle management practices for women with PCOS in Singapore.
    Ko H; Teede H; Moran L
    BMC Res Notes; 2016 Jun; 9():311. PubMed ID: 27306216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome.
    King J
    J Midwifery Womens Health; 2006; 51(6):415-22. PubMed ID: 17081931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic Ovary Syndrome, A Complex Entity Involving Reproductive and Metabolic Impairments: A Systematic Review.
    Amihăesei IC; Chelaru L; Lăcrămioara Zamfir C
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(4):755-9. PubMed ID: 30137754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
    Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
    Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACOG Practice Bulletin No. 194 Summary: Polycystic Ovary Syndrome.
    Obstet Gynecol; 2018 Jun; 131(6):1174-1176. PubMed ID: 29794670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polycystic ovary syndrome: is there a rise in the prevalence?].
    Carmona-Ruiz IO; Saucedo-de la Llata E; Moraga-Sánchez MR; Romeu-Sarró A
    Ginecol Obstet Mex; 2015 Dec; 83(12):750-9. PubMed ID: 27290799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment strategies for infertile women with polycystic ovary syndrome.
    Vitek W; Hoeger K; Legro RS
    Minerva Ginecol; 2016 Aug; 68(4):450-7. PubMed ID: 26765152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.